Novartis AG (NVSEF) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - General secteur d'activité. Le siège social de l'entreprise est situé à Basel, Switzerland. Le PDG actuel est Vasant Narasimhan.
NVSEF a date d'introduction en bourse 2010-04-26, 75,883 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $298.59B.
Novartis AG is a global healthcare company headquartered in Basel, Switzerland, that researches, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two primary segments: Innovative Medicines, which offers prescription medications across therapeutic areas including ophthalmology, neuroscience, immunology, cardiovascular, and respiratory medicine, and Sandoz, a leading generics and biosimilars business that manufactures and markets finished pharmaceuticals, active ingredients, and biotechnology-based products. Novartis maintains strategic collaborations with companies such as Alnylam Pharmaceuticals and Kura Oncology to advance its pipeline in areas like RNA interference therapeutics and oncology. The company serves patients, healthcare providers, and third-party pharmaceutical manufacturers across diverse markets globally.
